Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chemours Company
(NY:
CC
)
30.09
+0.17 (+0.57%)
Streaming Delayed Price
Updated: 2:12 PM EDT, Mar 22, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Chemours Company
< Previous
1
2
3
Next >
Chemours (CC) Q4 2022 Earnings Call Transcript
February 10, 2023
CC earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Analyst Expectations for Chemours's Future
February 10, 2023
Via
Benzinga
Chemours's Earnings Outlook
February 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Via
Benzinga
Analyst Ratings for Chemours
January 10, 2023
Via
Benzinga
Overview Of Value Stocks In The Basic Materials Sector
December 02, 2022
Via
Benzinga
Where Chemours Stands With Analysts
November 01, 2022
Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings:
Via
Benzinga
5 Value Stocks To Watch In The Basic Materials Sector
January 13, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023
January 11, 2023
Via
Benzinga
Chemours (CC) Q3 2022 Earnings Call Transcript
October 26, 2022
CC earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Earnings Scheduled For October 25, 2022
October 25, 2022
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter.
Via
Benzinga
Analyst Ratings for Chemours
October 13, 2022
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
January 10, 2023
Via
Benzinga
Expert Ratings for Chemours
September 23, 2022
Analysts have provided the following ratings for Chemours (NYSE:CC) within the last quarter:
Via
Benzinga
3 Undervalued Cruise Stocks to Buy Now
August 16, 2022
These undervalued cruise stocks have bounced back exceedingly well from the pandemic-led weakness and are benefitting from pent-up demand.
Via
InvestorPlace
Finding 20 Dividend Growth Stocks In A Bad Market
December 14, 2022
Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at...
Via
Talk Markets
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
December 02, 2022
There is a lot to like about The Chemours Company, but there is one issue that should give investors pause.
Via
The Motley Fool
10 Spin-Off Stocks That Pay Dividends
November 07, 2022
10 spin-offs from recent years that now pay dividends after being separated from their parent companies.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
October 05, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
McDonald's Price Target Cut By This Analyst, Plus Cowen Predicts $362 For Domino's Pizza
September 27, 2022
Citigroup cut McDonald's Corporation (NYSE: MCD) price target from $275 to $246. McDonald's shares rose 0.5% to $245.00 in pre-market trading.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
September 23, 2022
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero...
Via
Benzinga
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday
September 22, 2022
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth...
Via
Benzinga
Chemours, Alcoa And Other Big Losers From Wednesday
September 22, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
UBS Maintains Neutral Rating for Chemours: Here's What You Need To Know
July 29, 2022
UBS has decided to maintain its Neutral rating of Chemours (NYSE:CC) and raise its price target from $35.00 to $37.00. Shares of Chemours are trading up 3.55% over the last 24 hours, at $36.14 per...
Via
Benzinga
5 Analysts Have This to Say About Chemours
July 29, 2022
Over the past 3 months, 5 analysts have published their opinion on Chemours (NYSE:CC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...
Via
Benzinga
Recap: Chemours Q2 Earnings
July 28, 2022
Chemours (NYSE:CC) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Chemours beat estimated earnings by...
Via
Benzinga
How Does The Need Of Marketization Of HFCVs Impact PEM Industry?
July 26, 2022
As carbon neutral is becoming a consensus, the marketization of HFCVs is accelerating all over the world with its zero-carbon emission.
Via
Talk Markets
7 Small-Cap Stocks to Buy in July 2022
July 04, 2022
These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments.
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.